Drug maker Javelin hopes to meet with the Food and Drug Administration (FDA) to discuss approval of its new painkiller, Ereska. The drug is a non-opioid nasal medication designed to treat moderate to severe pain and provide physicians with an accepted and regulated alternative to off-label use and opioids.

Ereska is a formulation of ketamine, an anesthetic and analgesic that is also known on the streets as a “date rape” drug. It is well positioned to compete against Cephalon’s opioids Actiq and Fentora for breakthrough pain in cancer patients who have built up a resistance to opioids.

A 2007 study found Cephalon’s painkillers were most often used for the treatment of migraines and backaches, a use that is not approved by the FDA and found to cause serious adverse events in patients who have not already built up a tolerance to opioids. Javelin hopes Ereska will serve as an FDA-approved alternative for doctors and their patients seeking treatment for pain.

The world of painkillers is especially treacherous for drug makers, who have to tackle issues of narcotics abuse and safety issues with their products. Off-label use of Actiq and the more potent Fentora have been linked to fatal respiratory complications and associated with 127 deaths and 91 incidences of severe side effects.

Javelin’s Ereska may serve as a safer alternative; however, it isn’t foolproof. Phase III clinical trials for Ereska showed myriad hallucinatory and other psychomimetic effects in healthy volunteers taking sub-anesthetic doses of the drug, an issue that raises safety concerns among pain specialists.

Source: Behavioral Health Central 



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Fentanyl patches recalled due to accelerated release...

Potent pain patches used to treat breakthrough pain in cancer patients already on around-the-clock pain...

Fentanyl patches recalled due to danger of overdose

Potent pain patches used to treat breakthrough pain in cancer patients already on around-the-clock pain...

Cephalon files petition to block Fentora competition

Cephalon, maker of the potent pain killer Fentora, has filed a citizen petition to the Food and Drug...

56 dead from one clinic after taking Actiq for...

Fifty-six patients from one health care clinic have died and 96 others were sent to the emergency room...

FDA approves painkiller designed to be more difficult...

The Food and Drug Administration (FDA) has approved a new version of the painkiller OxyContin that is...

Types of potent painkillers approved only with...

When the Food and Drug Administration (FDA) approved the new opioid medication, Onsolis, last summer,...

Impressed with the Beasley Allen staff

I am very impressed with the Beasley Allen staff. They were very courteous and patiently explained the aspects of my claim in a way I could understand. If I ever have any need of an attorney in the future I will turn to Beasley Allen.

—Philip